Sildenofil in Persistent Pulmonary Hypertension in Newborns
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01558466
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01558466
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Qatar
- Registry status
- Unknown status
Technical summary
Registry record NCT01558466. Randomized; triple masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2014-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sildenofil in Persistent Pulmonary Hypertension in Newborns
- Acronym
- Sildeno
- Condition
- Persistent Fetal Circulation Syndrome
- Intervention (Drug)
- Sildenafil
- Intervention (Drug)
- diluent
- Lead sponsor
- Hamad Medical Corporation
Record details
- Record id
cardio:ct-nct01558466- Content hash
a1c847553948e4e99df85d8bd70465df2fccc518f4cdd466af74aee2e73f94b3